跳至主要内容
临床试验/JPRN-jRCT1031230368
JPRN-jRCT1031230368尚未招募Unknown

Effect of tirzepatide on oxidative stress and glucose variability in patients with type 2 diabetes mellitus

Ohara Makoto0 个研究点目标入组 66 人开始时间: 2023年9月27日最近更新:

试验速览

阶段
Unknown
状态
尚未招募
发起方
入组人数
66

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 20age old 至 ot applicable(—)
性别
All

入选标准

  • a diagnosis of type 2 diabetes mellitus
  • 1) HbA1c 7.0% or more
  • 2) Patients who were treated with regular doses of weekly GLP-1 receptor agonists at least for 12 weeks
  • 3) BMI >= 23
  • 4) written informed consent
  • 5) 20 years and over

排除标准

  • 1)the use of steroids or anti-inflammatory drugs,
  • 2)diabetic ketosis and coma within 3 months before the study,
  • 3)severe infection, severe trauma, pre-and post-operation,
  • 4)an estimated glomerular filtration rate are within 30mL/min/1.73m2,
  • 5)malignancy,
  • 6)pregnancy
  • 7)Patients who are judged as inappropriate for inclusion by phsicians
  • 8)Patients using implantable medical devices such as cardiac pacemakers

研究者

发起方
Ohara Makoto

相似试验